TJC0545
Fibrotic diseases
PreclinicalActive
Key Facts
About TaiwanJ Pharmaceuticals
TaiwanJ develops small‑molecule drugs for liver and inflammatory diseases using proprietary TLR4/Autotaxin platforms.
View full company profileTherapeutic Areas
Other Fibrotic diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Hydrogel Platform - Fibrosis Models | Ectica Technologies | Development |
| Fibrosis Program(s) | Focal Biosciences | Discovery |
| Fibrosis Target Program | Gero | Preclinical |
| SRK-441 | Scholar Rock Holding | Discovery |
| THB222 | Third Harmonic Bio | Preclinical |